Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine
The impact of depression is well described in the literature, and it is most prominent in patients who have trialed multiple treatments. Treatment-resistant depression (TRD) is particularly debilitating, and it is associated with significant morbidity and mortality. Despite this, there seems to be t...
Saved in:
Main Authors: | Linda Xing Yu Liu (Author), Marina Golts (Author), Virginia Fernandes (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Magnesium in Ketamine Administration in Treatment-Resistant Depression
by: Natalia Górska, et al.
Published: (2021) -
Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
by: Adam Włodarczyk, et al.
Published: (2023) -
The effectiveness of ketamine in medication of treatment-resistant depression - review
by: Patrycja Brzozowska, et al.
Published: (2024) -
Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
by: Aleksander Kwaśny, et al.
Published: (2023) -
Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression
by: Adam Włodarczyk, et al.
Published: (2021)